Literature DB >> 30063477

Hemostasis based on a novel 'two-path unifying theory' and classification of hemostatic disorders.

Jae C Chang1.   

Abstract

: Hemostasis is the most important protective mechanism for human survival following harmful vascular damage caused by internal disease or external injury. Physiological mechanism of hemostasis is partially understood. Hemostasis can be initiated by either intravascular injury or external bodily injury involving two different levels of damage [i.e., limited to the endothelium or combined with extravascular tissue (EVT)]. In intravascular injury, traumatic damage limited to local endothelium typically is of no consequence, but disease-induced endothelial damage associated with systemic endothelial injury seen in sepsis and other critical illnesses could cause generalized 'endotheliopathy'. It triggers no bleeding but promotes serious endothelial molecular response. If intravascular local trauma extends beyond the endothelium and into EVT, it causes intravascular 'bleeding' and initiate 'clotting' via normal hemostasis. In external bodily injury, local traumatic damage always extends to the endothelium and EVT, and triggers 'bleeding' and 'clotting'. Systemic endotheliopathy activates only unusually large von Willebrand factor multimers (ULVWF) path and mediates 'microthrombogenesis', producing 'microthrombi' strings. This partial activation of hemostasis with ULVWF path leads to vascular microthrombotic disease. But localized traumatic injury extending to the endothelium and EVT activates both ULVWF and tissue factor paths. Combined activation of ULVWF and tissue factor paths provides normal hemostasis in external bodily injury, but causes 'macrothrombus' formation in intravascular injury. This 'two-path unifying theory' concept succinctly elucidates simplified nature of hemostasis in intravascular and external bodily injuries. It also clarifies different pathogenesis of every hemorrhagic disease and thrombotic disorder related to internal vascular disease and external vascular injury.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30063477     DOI: 10.1097/MBC.0000000000000765

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  13 in total

Review 1.  COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy.

Authors:  Jae C Chang
Journal:  Vasc Health Risk Manag       Date:  2021-06-01

2.  The Use of Tranexamic Acid to Prevent Postpartum Hemorrhage.

Authors:  Ruth T Mielke; Sarah Obermeyer
Journal:  J Midwifery Womens Health       Date:  2020-05-19       Impact factor: 2.388

3.  Hypoxia and HIF activation as a possible link between sepsis and thrombosis.

Authors:  Colin E Evans
Journal:  Thromb J       Date:  2019-08-14

4.  Acute Respiratory Distress Syndrome as an Organ Phenotype of Vascular Microthrombotic Disease: Based on Hemostatic Theory and Endothelial Molecular Pathogenesis.

Authors:  Jae C Chang
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

5.  Stroke Classification: Critical Role of Unusually Large von Willebrand Factor Multimers and Tissue Factor on Clinical Phenotypes Based on Novel "Two-Path Unifying Theory" of Hemostasis.

Authors:  Jae C Chang
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

Review 6.  Thrombolytic Enzymes of Microbial Origin: A Review.

Authors:  Deepti Diwan; Zeba Usmani; Minaxi Sharma; James W Nelson; Vijay Kumar Thakur; Graham Christie; Gustavo Molina; Vijai Kumar Gupta
Journal:  Int J Mol Sci       Date:  2021-09-28       Impact factor: 6.208

Review 7.  Pathogenesis of Two Faces of DVT: New Identity of Venous Thromboembolism as Combined Micro-Macrothrombosis via Unifying Mechanism Based on "Two-Path Unifying Theory" of Hemostasis and "Two-Activation Theory of the Endothelium".

Authors:  Jae C Chang
Journal:  Life (Basel)       Date:  2022-01-31

Review 8.  Thromboembolic disease in COVID-19 patients: A brief narrative review.

Authors:  Samhati Mondal; Ashley L Quintili; Kunal Karamchandani; Somnath Bose
Journal:  J Intensive Care       Date:  2020-09-14

9.  rDromaserpin: A Novel Anti-Hemostatic Serpin, from the Salivary Glands of the Hard Tick Hyalomma dromedarii.

Authors:  Hajer Aounallah; Melissa Regina Fessel; Mauricio Barbugiani Goldfeder; Eneas Carvalho; Chaima Bensaoud; Ana Marisa Chudzinski-Tavassi; Ali Bouattour; Youmna M'ghirbi; Fernanda Faria
Journal:  Toxins (Basel)       Date:  2021-12-20       Impact factor: 4.546

10.  Thrombocytopenia in COVID‑19 and vaccine‑induced thrombotic thrombocytopenia.

Authors:  Marina Mantzourani; George P Chrousos; Styliani A Geronikolou; Işil Takan; Athanasia Pavlopoulou
Journal:  Int J Mol Med       Date:  2022-01-21       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.